Elite Pharmaceuticals Q4 EPS $0.01 Down From $0.02 YoY, Sales $40.748M Up From $31.996M YoY

Benzinga Newsdesk www.benzinga.com Negative 67.5%

Neg 67.5% Neu 0% Pos 0%

Elite Pharmaceuticals (OTC:ELTP) reported quarterly earnings of $0.01 per share. This is a 50 percent decrease over earnings of $0.02 per share from the same period last year. The company reported $40.748 million in sales this quarter. This is a 27.35 percent increase over sales of $31.996 million the same period last year.